← Back
$CRNX All transactions

Crinetics Pharmaceuticals, Inc.

▼ SELL 10b5-1 Plan

$ Value

$119K

Shares

3,000

Price

$40

Filed

Mar 4

Insider

Name

Okey Stephanie

Title

CIK

0001742616

Roles

Director

Transaction Details

Transaction Date

2026-03-03

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

13,300

Footnotes

The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2025. | The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a sale price of $39.67 per share.

Filing Info

Accession No.

0001628280-26-014775

Form Type

4

Issuer CIK

0001658247

Okey Stephanie's History

Date Ticker Type Value
2026-03-10 PTCT M $39K
2026-03-10 PTCT $82K
2026-03-10 PTCT M $471K
2026-03-10 PTCT $980K
2026-03-10 PTCT M $0
2026-03-10 PTCT M $0
2026-03-05 PTCT $401K
2026-03-03 CRNX $119K
2026-01-02 PTCT A $0
2026-01-02 PTCT A $0

Other Insiders at CRNX (90d)

Insider Bought Sold Last
Vivaldi Coelho Rogerio $181K 2026-03-12
Schilke Tobin
Chief Financial Officer
$266K 2026-03-03
Struthers Richard Scott
President & CEO
$822K 2026-03-16
Knight Jeff E.
Chief Dev. & Operating Officer
$3.4M 2026-04-08
Knight Jeff E.
Chief Operating Officer
$370K 2026-03-16
Betz Stephen F.
Chief Scientific Officer
$397K 2026-03-16
Kalofonos Isabel
Chief Commercial Officer
2026-02-23